I don't know, but it seems MGC is more interested in the Swiss technology "MyCells" now as Roby (or Robbie) said this technology is "vital" for them.
Sounds like a change of business direction to me. May be they have found that medical cannabis is not that profitable as they claimed before? Actually I have already pointed out the competition in the MM space at this moment is huge which makes the profit margin very low.
We may find out more updates at KORE genetics website?
Ann: Voluntary Suspension Extension, page-34
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.48M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.0¢ | 30.0¢ | $31.45K | 98.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 11528 | 2 |
View Market Depth
| Last trade - 12.44pm 05/09/2024 (20 minute delay) ? |
| RGT (ASX) Chart |